Clinical Trial Update: A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX [Phase 3]

View source ↗

Summary

Phase 3 study evaluating SM03 in active rheumatoid arthritis patients on MTX.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SM03

Snippet

Sponsor: SinoMab BioScience Ltd | Conditions: Rheumatoid Arthritis(RA) | Phase 3 | Status: UNKNOWN